Beta Drugs Ltd

Beta Drugs Ltd Performance

₹608
Day's Price Range
₹633
₹546.05
52-Week Price Range
₹1024.4
1 Month Return-5.19 %
3 Month Return-9.55 %
1 Year Return8.13 %

Insights on Beta Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years
    img

    In the last 3 years, BETA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise
    img

    In the last 3 years, BETA stock has moved up by 1428.8%

  • imgNO EFFECT

    FII Holding Unchanged
    img

    Foreign Institutions holdings remained unchanged at 0.29% of holdings in Dec 2022 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged
    img

    Promoters holdings remained unchanged at 66.71% of holdings in Dec 2022 quarter

  • imgNO EFFECT

    Retail Holding Unchanged
    img

    Retail Investor holdings remained unchanged at 32.96% of holdings in Dec 2022 quarter

  • imgNO EFFECT

    Against Peers
    img

    In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 8.4% return, outperforming this stock by 0.3%

Beta Drugs Ltd Shareholding Pattern

InvestorsHoldings %Prev. 4 periods3M change
Promoter Holdings
66.71%
0.00
Foreign Institutions
0.29%
0.00
Mutual Funds
0%
0.00
Retail Investors
32.96%
0.00
Others
0.04%
0.00

Beta Drugs Ltd Company Information

Beta Drugs Limited was incorporated as a private limited company with the name Beta Drugs Private limited at Himachal Pradesh on September 21 2005. Subsequently the company was converted in to public limited company and the name of the company was changed to Beta Drugs Limited on August 11 2017 Beta Drugs is a part of Adley Group. Adley Group was founded in the year 1985 by its promoter Vijay Batra who has more than twenty five years of experience in manufacture of pharmaceutical products in India. The Company is a pharmaceutical formulation manufacturing company engaged in developing manufacturing and marketing of drug products for domestic and international customers. The Promoter Vijay Batra took over the company from Kiran Goyal Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014. The company is primarily engaged in the manufacturing of oncology products. The Companys products range from anticancer tablets capsules injections and lyophilized injections. The Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31 2017 the company had a portfolio of over 50 products catering to various oncology diseases including breast brain bone lung mouth head neck prostate haematology cervics oeaophagus etc.

Beta Drugs Ltd Share Price: ₹626.95 per share as on 31 Mar, 2023 04:01 PM
Beta Drugs Ltd Market Capitalisation: ₹609.99Cr as of today
Beta Drugs Ltd Listing date: 10 Dec, 2017
Beta Drugs Ltd Chairperson Name: Rahul Batra
OrganisationBeta Drugs Ltd
HeadquartersBaddi
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Frequently Asked Questions

Beta Drugs Ltd(BETA) share price today is ₹626.95 (last updated 31 Mar, 2023 at 04:01 PM)

  • Today’s highest price of Beta Drugs Ltd(BETA) is ₹633.00.
  • Today’s lowest price of Beta Drugs Ltd(BETA) is ₹608.00.
  • (last updated 31 Mar, 2023 at 04:01 PM)
Today’s traded volume of Beta Drugs Ltd(BETA) is 1200.
Today’s market capitalisation of Beta Drugs Ltd(BETA) is ₹609.99Cr.
Beta Drugs Ltd(BETA)Price
52 Week High₹1024.40
52 Week Low₹546.05
  • (last updated 31 Mar, 2023 at 04:01 PM)
  • Beta Drugs Ltd(BETA) share price is ₹626.95 (last updated 31 Mar, 2023 at 04:01 PM). It is down -38.80% from its 52 Week High price of ₹1024.40
    Beta Drugs Ltd(BETA) share price is ₹626.95 (last updated 31 Mar, 2023 at 04:01 PM). It is up 14.82% from its 52 Week Low price of ₹546.05
    Beta Drugs Ltd(BETA)Returns (%)
    1 Day Returns2.53%
    1 Month Returns-5.19%
    1 Year Returns8.13%
    3 Year Returns1428.75%
    5 Year Returns388.61%
    Beta Drugs Ltd(BETA) share price is ₹626.95 and its price to earning (PE) is 0.00. A high PE ratio indicates that a share price is overvalued, or investors are expecting a high growth rate in the future.